Established Research Grant 2017 – Prof. Michelle Haber

    NAME Prof. Michelle Haber
    CANCER TYPE Leukaemia
    INSTITUTION University of NSW, Children's Cancer Institute of Australia
    STATE New South Wales
    GRANT TYPE $200,000
    PROJECT TYPE Research

    "A promising new drug, CBL0137, blocks cancer cell growth by inhibiting the cancer‐associated protein, FACT. Leukaemia in infants is normally very hard to treat, despite intensive regimens... However this new agent potently kills infant leukaemia cells and we propose to develop CBL0137 for clinical use in children with aggressive leukaemia."

    Professor Michelle Haber, Leukaemia researcher for UNSW and the Children's Cancer Institute